1Malone FD,Canick JA,Ball RH. First-trimester and second-trimester screening,or both,for Down's syndrome[J].New England Journal of Medicine,2005,(19):2001-2011.
2Ball RH,Caughey AB,Malone FD. First and second trimester evaluation of risk(faster) research consortium.first-and second-trimester evaluation of risk for Down's syndrome[J].OBSTETRICS AND GYNECOLOGY,2007,(01):10-17.
3Wald NJ,Rodeck C,Hackshaw AK. Suruss in perspective[J].British Journal of Obstefrics and Gynaecology,2004,(06):521-531.
4Hsu JJ,Hsieh TF,Soong YK. The influence of maternal weight correction formulas in asian Down syndrome screening using alpha-fetoprotein and free beta-human chorionic gonadortropin[J].J Matem Fetal Investig,1998,(02):66-70.
7Wald NJ,Rodeck C,Hackshaw AK. First and second trimester antenatal screening for Down's syndrome:the results of the serum,urine and ultrasound screening study (SURUSS)[J].HEALTH TECHNOLOGY ASSESSMENT,2003,(11):1-77.
4Snijders RJM,Noble P,Sebire N,et al.UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchaltranslucency thickness at 10-14 weeks of gestation. Lancet,The . 1998
5Cuckle HS,Wald NJ,Lindenbaum RH.Maternal serum alpha-fetoprotein measurement:a screening test for Down syndrome. The Lancet . 1984
6Wald NJ,Densem JW.Maternal serum free alpha-human chorionic gonadotrophin levels in twin pregnancies:implica-tions for screening for Down’’s syndrome. Prenatal Diagnosis . 1994
